THD NewsDesk, New Delhi: Dec 19 (IANS) The All India Institute of Medical Sciences (AIIMS) on Friday sought a listing of MBBS students, nursing students, and fellows from its different agencies who will be supplying the Covid vaccines on a preference basis in the initial stage of the inoculation approach.
The program was sought as the Union Health Ministry is preparing a database of healthcare workers and other healthcare settings to get the vaccine shot after its rollout.
The Central administration intends to vaccinate approximately 30 crore people in the initial stage of the drive. It will be offered to one crore healthcare workers, simultaneously with two crore frontline and primary workers and 27 crores elderly, mostly above the age of 50 years with comorbidities.
The department has advised countries and union territories to upload healthcare workers’ data on its digital application – Covid-19 Vaccine Intelligence Network (COVIN).
In a notice, AIIMS Registrar Sanjay Lalwani asked the chief of centers, head of departments, principal college of nursing, and hostel superintendent to send the copy of identity cards (IDs) and their numbers in excel sheet latest by December 19.
The AIIMS administration has also sought IDs of senior residents, junior residents, fellows, MBBS students, paramedical students, B.Sc. (Hons.) nursing students, and B.Sc Nursing working or studying under their supervision “for onward transmission to the computer facility for receiving the Covid-19 vaccine.”
India has eight Covid-19 vaccine candidates, including three indigenous vaccines, under different clinical trial stages, ready for authorization shortly.
It includes Oxford university developed AstraZeneca, Serum Institute of India manufactured Covishield, Covaxin by Bharat Biotech Limited, ZyCoV-D by Zydus Cadila, and Russian vaccine candidate Sputnik-V.
The list also contains NVX-CoV2373 by SII, HGCO19 by Geneva, and two unlabeled vaccines-Recombinant Protein Antigen based vaccine by Biological E Limited-and Inactivated rabies vector platform by Bharat Biotech.
Source: IANS
